Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine

Sehatpour, P., Iosifescu, D. V., De Baun, H. M., Shope, C., Mayer, M. R., Gangwisch, J., Dias, E., Sobeih, T., Choo, T.-H., Wall, M. M., Medalia, A., Saperstein, A. M., Kegeles, L. S., Girgis, R. R., Carlson, M., & Kantrowitz, J. T. (2023). Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine. Biological Psychiatry, 94(2), 164–173. https://doi.org/10.1016/j.biopsych.2023.01.015
Authors:
Pejman Sehatpour
Dan V Iosifescu
Heloise M De Baun
Constance Shope
Megan R Mayer
James Gangwisch
Elisa Dias
Tarek Sobeih
Tse-Hwei Choo
Melanie M Wall
Alice Medalia
Alice M Saperstein
Lawrence S Kegeles
Ragy R Girgis
Marlene Carlson
Joshua T Kantrowitz
Affiliated Authors:
Pejman Sehatpour
James Gangwisch
Tse-Hwei Choo
Melanie M Wall
Alice Medalia
Alice M Saperstein
Lawrence S Kegeles
Ragy R Girgis
Marlene Carlson
Joshua T Kantrowitz
Subjects:
Author Keywords:
auditory learning
clinical trial
mismatch negativity
nmda receptor
schizophrenia
target engagement
Publication Type:
Article
Unique ID:
10.1016/j.biopsych.2023.01.015
PMID:
Publication Date:
Data Source:
PubMed

Record Created: